Project Grant HT94252410523
- This federal Project Grant award in the amount of $1,700,000 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the California Institute of Technology (Caltech) for the project "ROLE OF THE SKD3 CHAPERONE IN MAINTAINING MITOCHONDRIAL PROTEIN QUALITY CONTROL". The purpose of this 4-year award, with a performance period from May 1, 2024 to April 30, 2028, is to conduct basic, applied, and advanced biomedical research...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $2.72 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025, through July 14, 2029. The award supports advanced biomedical research titled "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging," which will...
- This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
- The Defense Health Agency awarded a $311,000 Project Grant to the University of Washington under the Military Medical Research and Development federal grant program (CFDA 12.420) to manage mitochondrial disorders through increased intestinal fermentation and reduced metabolic burden from January 1, 2023 to December 31, 2024. The University of Washington will deliver research to transform health care for service members and the public by investigating medical solutions for the battlefield through...
- Federal Grant Award Summary The University of California, San Francisco received a $973,947 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on July 15, 2025, with a completion date of July 14, 2029. The award funds research on imaging cardiac metabolic flux and mitochondrial function using hyperpolarized 13C (HP 13C) and Chemical Exchange Saturation Transfer (CEST) metabolic magnetic resonance imaging. The research...
- Federal Grant Award Summary The Sloan-Kettering Institute for Cancer Research received a $176,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2026. This award supports research investigating the interactions of mitochondrially encoded Complex I mutations with hypoxia and antitumor immune response in chromophobe renal cell carcinoma. The research aims to advance...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This federal Project Grant award of $1,696,098.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting California Institute of Technology (Caltech) in conducting research on the role of the SKD3 chaperone in maintaining mitochondrial protein quality control. The award has a performance period of May 1, 2024 through April 30, 2028. This research aims to advance the understanding of mitochondrial function and protein regulation, which could yield insights to improve health outcomes for military service members and the broader public. As a leading research university, Caltech has a strong track record of delivering innovative scientific discoveries and technical solutions to federal agencies like the Department of Defense through both prime contract and grant awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.7m | 4/30/24 |